Randomized phase 2 trial of the Vincristine-Irinotecan combination with or without Temozolomide, in children and adults with relapsed or refractory rhabdomyosarcoma: an EpSSG/ITCC trial.
MetadataShow full item record
Sarcoma Clinical Trials in children and young people
License start date
Journal of Clinical Oncology
American Society of Clinical Oncology